33 results
8-K
EX-99.1
ABSI
Absci Corp
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
, spearheading the development of connected, patient-centric solutions. This focus seamlessly aligns with Absci's commitment to accelerating the pace … the company’s commitment to assembling a distinguished group of industry leaders with a shared vision for advancing AI and science toward breakthrough
8-K
EX-99.1
ABSI
Absci Corp
21 Mar 24
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
7:31am
poised to further advance our pipeline, enhance our AI capabilities, and expand our partnerships. These efforts reflect our commitment to innovation … target. Under the terms of the collaboration agreement, Absci is entitled to receive an upfront commitment, research and development funding, and milestone
8-K
ABSI
Absci Corp
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
release provides that the Company is entitled to receive an upfront commitment, research and development funding, and milestone payments, collectively
8-K
EX-99.1
ABSI
Absci Corp
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
AI technology to deliver a therapeutic candidate antibody for a specified oncology target. The agreement includes an upfront commitment, R&D funding
8-K
EX-99.2
dd1kw
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
8-K
EX-99.2
rts4jrhsv0i26ziwi
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-3.2
4oi78c
26 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
PRE 14A
lh86znn6ba ep3fu
11 Apr 23
Preliminary proxy
5:49pm
8-K
coh44t8iabzrrhst7al1
27 Feb 24
Results of Operations and Financial Condition
4:45pm
DEF 14A
q5rt34qy0b
26 Apr 22
Definitive proxy
4:39pm
8-K
EX-3.1
xs6z38u pibp2vys
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
S-1/A
EX-2.1
2w6 n5f6wvddl
8 Jul 21
IPO registration (amended)
5:04pm
DRS/A
EX-3.1
1hmkjt u4lvadig4g
16 Jun 21
Draft registration statement (amended)
12:00am
S-1
EX-3.1
y9wvql3prkj4pky
30 Jun 21
IPO registration
3:20pm
8-K
EX-1.1
i6oahvf7avego
16 Jun 23
Entry into a Material Definitive Agreement
4:23pm